2019
DOI: 10.3389/fonc.2019.00754
|View full text |Cite
|
Sign up to set email alerts
|

SIRT5 Promotes Cisplatin Resistance in Ovarian Cancer by Suppressing DNA Damage in a ROS-Dependent Manner via Regulation of the Nrf2/HO-1 Pathway

Abstract: Sirtuin 5 (SIRT5), a mitochondrial class III NAD-dependent deacetylase, plays controversial roles in tumorigenesis and chemoresistance. Accordingly, its role in ovarian cancer development and drug resistance is not fully understood. Here, we demonstrate that SIRT5 is increased in ovarian cancer tissues compared to its expression in normal tissues and this predicts a poor response to chemotherapy. SIRT5 levels were also found to be higher in cisplatin-resistant SKOV-3 and CAOV-3 ovarian cancer cells than in cis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
54
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 78 publications
(54 citation statements)
references
References 63 publications
0
54
0
Order By: Relevance
“…Furthermore, recurrence of ovarian cancer is up to 75% and the recurrent cancer can result in the acquisition of cisplatin resistance, as well [ 43 ]. Thus, cisplatin resistance is a limitation of cisplatin chemotherapy, since there are several molecular mechanisms leading to cisplatin resistance [ 45 , 46 , 47 ]. Among the mechanical reasons, previous studies showed that upregulation of FOXM1 induced cisplatin resistance in several cancer cells [ 48 , 49 , 50 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, recurrence of ovarian cancer is up to 75% and the recurrent cancer can result in the acquisition of cisplatin resistance, as well [ 43 ]. Thus, cisplatin resistance is a limitation of cisplatin chemotherapy, since there are several molecular mechanisms leading to cisplatin resistance [ 45 , 46 , 47 ]. Among the mechanical reasons, previous studies showed that upregulation of FOXM1 induced cisplatin resistance in several cancer cells [ 48 , 49 , 50 ].…”
Section: Discussionmentioning
confidence: 99%
“…Glutathione (GSH). ROS induced by apatinib was determined using a ROS Assay Kit (Beyotime, Shanghai, China) according to the manufacturer's protocol as previously described [16]. Briefly, after exposure to apatinib (0, 10, and 20 μM) for 24 h, the cells were incubated with 10 μM 2 ′ -7 ′ dichlorofluorescin diacetate (DCFH-DA) in the dark for 20 min at 37°C in a humidified atmosphere at 5% CO 2 .…”
Section: Ros Detection and Measurement Of Intracellularmentioning
confidence: 99%
“…Oxidative Medicine and Cellular Longevity A Total Glutathione Assay Kit (Beyotime) was used to measure intracellular GSH levels according to the manufacturer's instructions as previously described [16]. Briefly, after being cocultured with or without apatinib for 24 h and/or pretreated with 200 μM TBHQ for 4 h to activate the Nrf2 pathway, cells were harvested and lysed in the protein removal solution S provided in the kit.…”
mentioning
confidence: 99%
“…SIRT4, on the other hand, arrests cell cycle progression in response to DNA damage, providing more time for DNA repair, and thus delaying apoptosis [48]. SIRT5 possesses multiple enzymatic activities but little is known considering its role in DNA repair [49]. The role of sirtuins in DNA repair has been summarized in Figure 2.…”
Section: Sirtuinsmentioning
confidence: 99%